4//SEC Filing
Mitchell Shawnte 4
Accession 0001019056-19-000182
CIK 0001671584other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:08 PM ET
Size
10.8 KB
Accession
0001019056-19-000182
Insider Transaction Report
Form 4
Mitchell Shawnte
SVP, GC and Corporate Affairs
Transactions
- Tax Payment
Common Stock
2019-03-01$1.57/sh−2,012$3,159→ 80,527 total - Award
Stock Option (right to buy)
2019-02-28+67,400→ 67,400 totalExercise: $1.52Exp: 2029-02-28→ Common Stock (67,400 underlying) - Exercise/Conversion
Restricted Stock Unit
2019-03-01−6,787→ 0 total→ Common Stock (6,787 underlying) - Exercise/Conversion
Common Stock
2019-03-01+6,787→ 82,539 total
Footnotes (3)
- [F1]Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis.
- [F2]The option vests in three approximately equal annual installments beginning on February 28, 2020.
- [F3]On March 1, 2016 the reporting person was granted 20,365 restricted stock units. 6,789 shares of common stock underlying the restricted stock units vested on each of March 1, 2017 and March 1, 2018, and the remaining 6,787 shares vested on March 1, 2019.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001749432
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:08 PM ET
- Size
- 10.8 KB